Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,443,888
+$941,404 QoQ
Shares Held
3,705
-2.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#1,805
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 14%
Shared 0%
None 86%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Estabrook Capital Management holds $58,767,979 across 13 Drug Manufacturers - General names. LLY ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,720 | $22,786,188 | |
| 2 | MRK |
Merck & Co., Inc.
|
96,811 | $12,440,213 | |
| 3 | PFE |
Pfizer Inc
|
324,099 | $7,804,303 | |
| 4 | AMGN |
Amgen Inc
|
18,721 | $6,779,248 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
3,705 | $4,443,888 | |
| 6 | ABBV |
AbbVie Inc.
|
12,861 | $3,236,342 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,515 | $548,254 | |
| 8 | BIIB |
Biogen Inc.
|
2,000 | $432,120 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,443,888 | 3,705 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,502,484 | 3,808 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,085,933 | 3,802 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,099,306 | 4,062 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,185,939 | 4,087 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,871,040 | 4,687 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,517,744 | 5,852 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,398,918 | 6,094 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,060,613 | 6,694 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,545,298 | 7,128 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,468,664 | 7,666 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,370,089 | 8,136 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,166,887 | 8,885 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,327,739 | 9,690 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,508,405 | 9,590 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,210,865 | 9,930 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,357,401 | 10,355 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,008,603 | 10,506 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,088,415 | 11,181 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,035,997 | 13,140 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,098,520 | 13,500 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,553,829 | 13,670 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,358,694 | 13,970 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,094,779 | 14,152 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,422,475 | 14,755 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,060,685 | 14,855 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||